ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model.
Schuster-Gaul S, Geisler LJ, McGeough MD, Johnson CD, Zagorska A, Li L, Wree A, Barry V, Mikaelian I, Jih LJ, Papouchado BG, Budas G, Hoffman HM, Feldstein AE.
Schuster-Gaul S, et al. Among authors: zagorska a.
JCI Insight. 2020 Jan 30;5(2):e123294. doi: 10.1172/jci.insight.123294.
JCI Insight. 2020.
PMID: 31996485
Free PMC article.